PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER

The impact of pathological complete response (pCR) on long-term treatment outcomes was analyzed in patients with locally advanced gastric cancer, who received prolonged neoadjuvant chemoradiotherapy.Material and Methods. The study included 45 patients with locally advanced gastric cancer. Neoadjuvan...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. Yu. Skoropad, D. D. Kudriavtsev, L. N. Titova, S. A. Moserov, T. A. Agababyan, S. A. Ivanov, A. D. Kaprin
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2020-07-01
Series:	Сибирский онкологический журнал
Subjects:	gastric cancer neoadjuvant chemoradiotherapy combined modality treatment pathological
Online Access:	https://www.siboncoj.ru/jour/article/view/1485
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and morphological response to neoadjuvant chemotherapy followed by chemoradiotherapy in a patient with locally advanced gastric cancer: a case report
by: V. Yu. Skoropad, et al.
Published: (2023-06-01)

Impact of the histological regression grade of the primary tumor and regional lymph nodes after neoadjuvant chemoradiotherapy on survival of patients with gastric cancer: two case reports
by: V. Yu. Skoropad, et al.
Published: (2020-04-01)

ASSESSMENT OF HISTOPATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN GASTRIC CANCER PATIENTS: A MULTI-CENTER RANDOMIZED STUDY
by: V. Yu. Skoropad, et al.
Published: (2020-10-01)

Assessment of the safety and feasibility of neoadjuvant chemotherapy (2 cycles of FLOT chemotherapy + chemoradiotherapy) followed by surgery in the treatment of locally advanced gastric cancer
by: D. Yu. Mironova, et al.
Published: (2024-03-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

ANALYSIS OF SAFETY OF NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER (RESULTS OF A MULTICENTER RANDOMIZED TRIAL)
by: V. Yu. Skoropad, et al.
Published: (2020-09-01)

Spleen-preserving D2 subtotal distal resection of the stomach and corpocaudal resection of the pancreas after neoadjuvant induction chemotherapy and chemoradiotherapy: case report and literature review
by: V. Yu. Skoropad, et al.
Published: (2022-11-01)

Opportunities and limitations of CT - assessment of neoadjuvant chemoradiation therapy of gastric cancer
by: T. A. Agababyan, et al.
Published: (2019-12-01)

Risk factors of pathologic complete response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Liangjing Zhou, et al.
Published: (2025-07-01)

PATHOLOGICAL RESPONSE OF GASTRIC CANCER TO NEOADJUVANT PROLONGED CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY
by: Е. F. Lushnikov, et al.
Published: (2016-02-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
by: Yue Guo, et al.
Published: (2025-02-01)

PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-03-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

SURGICAL TREATMENT OF REGIONAL RECURRENCE FROM GASTRIC CANCER AFTER MULTIMODAL TREATMENT WITH NEOADJUVANT CHEMORADIOTHERAPY (A CASE REPORT)
by: V. Yu. Skoropad, et al.
Published: (2018-05-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

Multi‐Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
by: Fangdong Zhao, et al.
Published: (2025-02-01)

Development and validation of nomogram for predicting pathological complete response to neoadjuvant chemotherapy and immunotherapy for locally advanced gastric cancer: a multicenter real-world study in China
by: Hao Cui, et al.
Published: (2025-07-01)

The Influence of Neoadjuvant Chemoradiotherapy on Muscle Mass in Patients with Rectal Cancer
by: Gregory Simpson, et al.
Published: (2019-07-01)

Carcinoembryonic antigen trajectory predicts pathological complete response in advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2025-02-01)

Dual energy CT-derived quantitative parameters and hematological characteristics predict pathological complete response in neoadjuvant chemoradiotherapy esophageal squamous cell carcinoma patients
by: Miaomiao Li, et al.
Published: (2025-05-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
by: Canjun Li, et al.
Published: (2025-04-01)

Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer
by: Shanshan Bu, et al.
Published: (2025-04-01)

Complete histopathological regression in rectal cancer after neoadjuvant chemoradiotherapy and sphincter preserving surgical treatment
by: Petrović Tomislav, et al.
Published: (2018-01-01)

MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis
by: Zhongfan Liao, et al.
Published: (2025-03-01)

Long‐Term Survival Analysis of Neoadjuvant Chemoradiotherapy Versus Adjuvant Chemoradiotherapy for Locally Advanced Low Rectal Cancer
by: Siyuan Chen, et al.
Published: (2025-08-01)

Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
by: N. V. Severskaya, et al.
Published: (2018-11-01)

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection
by: Elyar Abaydulla, et al.
Published: (2025-12-01)

Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis
by: Yonghe Chen, et al.
Published: (2025-01-01)

Multi-modal radiomics model based on four imaging modalities for predicting pathological complete response to neoadjuvant treatment in breast cancer
by: Yuwen Liang, et al.
Published: (2025-06-01)

Clinical case of pathological complete response of gastric cancer after one cycle of neoadjuvant chemotherapy with fot regimen
by: V. Yu. Skoropad, et al.
Published: (2023-01-01)

Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
by: Nai-Yu Lin, et al.
Published: (2025-07-01)

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01)

Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
by: Rongxin Zhang, et al.
Published: (2025-08-01)

Surgical management of cancer of the stomach and gastroesophageal junction after neoadjuvant therapy: the experience of the MRRC and literature review
by: V. Yu. Skoropad, et al.
Published: (2023-02-01)

Predictive factors of pathological complete response after neoadjuvant therapy for locally advanced rectal cancer
by: LI Hao, LUO Yang, WANG Tingfeng, LIN Haiping, GONG Tingyue, ZHAO Yongheng, ZHONG Ming
Published: (2025-01-01)

The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Yunus Emre Altıntaş, et al.
Published: (2025-05-01)